Chapters 1 and 2 will coincide with RAP'S lodgement for FDA approval, so agreed timing wise it is pretty good. Not expecting shareholders to be offered any of that $3mill required because I think Insto's will be all over this.
MNQ Price at posting:
2.3¢ Sentiment: None Disclosure: Held